MSB 3.83% $1.26 mesoblast limited

MSB 2022 - The road to commercialisation, page-815

  1. 192 Posts.
    lightbulb Created with Sketch. 137
    I believe it has been shown in a few of Meso clinical trials that our therapy works in heathier patients that still have a descent immune system. Our cells call in the curing cells if they are available. Thats why the trials did poorly when we treated the sickest of the sick. They set us up for failure and ended the trial early.
    I have not seenmuch talk here about the fda changing approvoals of new drugs based on real world evidence and comparisions to historical trials instead of placebo.
    Perhaps a new paradigm might be coming.
    I se Biden talking about new therapies being approved in sept oct before midterm ellections
    GL my Auzzie friends

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.